# Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH

> **NCT05023824** · PHASE3 · UNKNOWN · sponsor: **Gangnam Severance Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Prostatic Hyperplasia
- Prostate Hyperplasia
- Prostatic Hypertrophy

## Interventions

- **DRUG:** alpha-blocker or 5-ARI withdrawal
- **DRUG:** Maintenance of alpha-blocker and 5-ARI

## Key facts

- **NCT ID:** NCT05023824
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-08
- **Primary completion:** 2023-12-07
- **Final completion:** 2023-12-07
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05023824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05023824, "Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05023824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*